Rhoen-Klinikum AG Celebrates Stellar Financial Success in 2023

• RHÖN-KLINIKUM AG had a successful financial year in 2023, meeting its financial targets as per forecast.
• The company's revenues increased by 17.9 million euros to 1,464.0 million euros, despite the discontinuation of reimbursements from the legislator under COVID-19 legislation.
• Consolidated profit improved by 13.3 million euros to 40.2 million euros. Earnings before interest, taxes, depreciation and amortisation (EBITDA) stood at 105.9 million euros.
• A total of 881,775 patients were treated on an inpatient and outpatient basis in the Group’s hospitals and medical care centres – an increase of 3.1 per cent.
• The company is investing in the expansion of outpatient care and digitalisation, and is aiming to achieve CO2-greenhouse gas neutrality in Scope 1 and Scope 2 emissions by financial year 2040.
• For the coming financial year, the company expects revenues of 1.6 billion euros within a range of +/- 5 per cent and EBITDA between 110 million euros and 120 million euros.

The next important date, Publication of the Annual Financial Report 2023, at Rhoen-Klinikum is on 28.03.2024.

The price of Rhoen-Klinikum at the time of the news was 10,900EUR and was down -0,91 % compared with the previous day.

Rhoen-Klinikum

+0,78 %

+18,35 %

+19,44 %

+29,65 %

-3,01 %

-17,20 %

-50,38 %

-45,34 %

+14.900,00 %

ISIN:DE0007042301WKN:704230

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max